6 results match your criteria: "and Suburban Hospital[Affiliation]"
Neurology
March 2021
From the Stroke Branch (A.W.H., M.L.L., R.L., J.K.L., Z.N., R.T.B., C.K., S.P.B., L.L.), NIH/National Institute of Neurological Disorders and Stroke, Bethesda, MD; MedStar Washington Hospital Center (A.W.H., R.T.B., C.K., S.P.B.), Washington, DC; and Suburban Hospital (Z.N.), Johns Hopkins Medicine, Bethesda, MD.
Objective: To determine the IV tissue plasminogen activator (tPA) treatment rate of patients with minor acute ischemic stroke (mAIS) at our centers and compare the frequency of MRI targets by treatment stratification and clinical severity, we evaluated clinical characteristics and baseline MRIs for tPA-treated and untreated patients.
Methods: Patients with ischemic stroke from 2015 to 2017 with admit NIH Stroke Scale (NIHSS) <6 were considered. The treated cohort received standard IV tPA and was screened with baseline MRI.
Neurology
July 2017
From Stroke Diagnostics and Therapeutics Section (T.M.B., M.L., Z.N., R.T.B., J.K.L., L.L.L., A.W.H.), National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD; MedStar Washington Hospital Center Comprehensive Stroke Center (R.T.B., A.W.H.), Washington, DC; and Suburban Hospital Stroke Center (Z.N.), Bethesda, MD.
Objective: To determine to what degree stroke mimics skew clinical outcomes and the potential effects of incorrect stroke diagnosis.
Methods: This retrospective analysis of data from 2005 to 2014 included IV tissue plasminogen activator (tPA)-treated adults with clinical suspicion for acute ischemic stroke who were transferred or admitted directly to our 2 hub hospitals. Primary outcome measures compared CT-based spoke hospitals' and MRI-based hub hospitals' mimic rates, hemorrhagic transformation, follow-up modified Rankin Scale (mRS), and discharge disposition.
Am J Alzheimers Dis Other Demen
February 2017
7 Department of Neurology, Johns Hopkins Community Physicians and Suburban Hospital, Johns Hopkins Medicine, Bethesda, MD, USA.
Montreal Cognitive Assessment (MoCA) test has been shown to be a reliable tool to detect mild cognitive impairment (MCI), however, no Georgian language version exists. The goal of this study is to determine the validity, reliability, and accuracy of Georgian version of MoCA in the evaluation of amnestic MCI (aMCI) and Alzheimer's disease (AD). Montreal Cognitive Assessment was translated into Georgian language and was administered to healthy participants (HP) and patients with aMCI and AD.
View Article and Find Full Text PDFSouth Med J
August 2016
From the Johns Hopkins University School of Medicine, Baltimore, and Suburban Hospital, Bethesda, Maryland.
Objectives: Changes in the US healthcare economic system are requiring academic health centers (AHCs) to restructure in pursuit of their traditional tripartite missions; engaging the individuals focused on clinical care is becoming more important. We conducted this study to guide our institution's transformation by identifying ways to formally recognize clinicians who are excelling in patient care and understand which forms of acknowledgment would be acceptable and motivating.
Methods: A survey was developed by a large committee with representation spanning the AHC and was sent electronically in spring 2014 to stakeholders across the institution.
Neurology
June 2015
From the Section on Stroke Diagnostics and Therapeutics (S.S., M.L., K.P., T.M., R.T.B., J.K.L., Z.N., A.W.H.), National Institute of Neurological Disorders and Stroke, Bethesda, MD; MedStar Washington Hospital Center Stroke Center (K.P., E.K., R.T.B., A.W.H.), Washington, DC; and Suburban Hospital Stroke Program (T.M., Z.N.), Bethesda, MD.
Objective: The objective of this study was to demonstrate the feasibility of timely multimodal MRI screening before thrombolysis in acute stroke patients.
Methods: Quality improvement processes were initiated in 2013 to reduce door-to-needle (DTN) time at the 2 hospitals where the NIH stroke team provides clinical care. Acute ischemic stroke (AIS) patients who received IV tissue plasminogen activator (tPA) ≤4.
J Am Coll Cardiol
April 2006
Laboratory of Cardiac Energetics, National Heart, Lung, and Blood Institute, National Institutes of Health, and Suburban Hospital, Bethesda, Maryland 20892-1061, USA.
Objectives: This study was designed to determine the diagnostic value of adenosine cardiac magnetic resonance (CMR) in troponin-negative patients with chest pain.
Background: We hypothesized that adenosine CMR could determine which troponin-negative patients with chest pain in an emergency department have coronary artery disease (CAD) or future adverse cardiac events.
Methods: Adenosine stress CMR was performed on 135 patients who presented to the emergency department with chest pain and had acute myocardial infarction (MI) excluded by troponin-I.